Randomized Phase II Study of PET Response–Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial Patients with medically inoperable and/or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results